Dewberry is a modern hybrid-indica strain whose exact origins remain undocumented. While the lineage is partially linked to Northern Lights, breeders have not publicly confirmed the complete genetic cross, and its path to market lacks a comprehensive or official history. This lack of documentation is common for the variety, and there is no confirmed record of recognized breeders or specific development timelines associated with the strain.

The chemical expression of Dewberry is characterized by a specific terpene profile. While confirmation exists for its constituent compounds, the dominance shift from caryophyllene to myrcene and caryophyllene-oxide likely informs its complex aromatic and flavor experience. Notes of linalool, nerolidol, and pinene follow in the composition, with trace contributions from beta-pinene, limonene, camphene, ocimene, isopulegol, gamma-terpinene, terpinolene, and humulene. Users can expect an estimated THC content of 14.8%, complemented by an estimated 0.02% CBD and 0.11% CBG.

Dewberry produces effects that are firmly relaxed and focused, making it a functional option for addressing pain, stress, and sleep. The strain is suitable for cultivation in both indoor and outdoor environments, maintaining a flowering time of 63 days. While its growth difficulty is rated as moderate, it is capable of producing a high yield. Despite its presence in the modern market, there are no notable offspring currently recorded for this strain.